Midas Pharma GmbH has a total of 12 patent applications. It decreased the IP activity by 25.0%. Its first patent ever was published in 2013. It filed its patents most often in Australia, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and packaging and shipping are CAMBRIDGE BIOSTABILITY LTD, SAOL INTERNATIONAL LTD and NAHEED SHABANA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Brazil | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Packaging and shipping |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Syringes | |
#3 | Therapeutic chemical compounds | |
#4 | Packaging |
# | Name | Total Patents |
---|---|---|
#1 | Kahm Andreas | 5 |
#2 | Dunne Stephen | 4 |
#3 | Jünemann Daniel | 4 |
#4 | Becker Karin | 2 |
#5 | Hussein Khaled | 2 |
#6 | Werner Karl | 2 |
#7 | Emmott Douglas Arthur | 2 |
#8 | Milak Spomenka | 2 |
#9 | Dachtler Markus | 2 |
#10 | Oakley Tom | 1 |
Publication | Filing date | Title |
---|---|---|
EP3545949A1 | Oral dosage forms comprising pomalidomide crystalline form a | |
EP3501502A1 | Fixed dosed pharmaceutical compositions comprising amlodipine, ramipril and atorvastatin | |
AU2013349611A1 | Auto-injector assembly |